Rhenium Re-188 P2045
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rhenium Re-188 P2045, covering 2022-11-07 to 2022-11-07. Get the full timeline:
Most recent: Clinical Trial Update: Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy [Phase 1, Phase 2]